Brief: Avalo Reports 2022 Financial Results And Provides Business Updates

Avalo Therapeutics

29/03/2023 12:36

March 29 (Reuters) - Avalo Therapeutics Inc  AVTX.O :
    * AVALO REPORTS 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS
UPDATES
    * AVALO THERAPEUTICS INC - AVALO HAD $13.2 MILLION IN CASH
AND
CASH EQUIVALENTS AS OF DECEMBER 31, 2022,
    * AVALO THERAPEUTICS INC - FY NET LOSS PER SHARE OF COMMON
STOCK,
BASIC AND DILUTED $4.43

Source text for Eikon:  ID:nGNX3hJSHv 
Further company coverage:  AVTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))